Previous Close | 2.1800 |
Open | 2.0100 |
Bid | 2.0400 x 0 |
Ask | 2.0700 x 0 |
Day's Range | 2.0100 - 2.0700 |
52 Week Range | 1.9100 - 2.7900 |
Volume | |
Avg. Volume | 3,767 |
Market Cap | 51.389M |
Beta (5Y Monthly) | 1.29 |
PE Ratio (TTM) | 34.17 |
EPS (TTM) | 0.0600 |
Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2022 fourth quarter and year end results for the period ended September 30, 2022.
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2022 financial results on Wednesday, January 25th, 2023, after markets close. A conference call and webcast to discuss the financial results will be held on Thursday, January 26th, 2023 at 9:00am EST.
The Planet MicroCap Showcase: VIRTUAL taking place on December 6-8, 2022, where 49 MicroCap public companies will be presenting virtually.